Cumberland Pharmaceuticals (CPIX) Goodwill & Intangibles (2010 - 2026)

Cumberland Pharmaceuticals has reported Goodwill & Intangibles for 17 years, with the latest figure at $13.7 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 23.43% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (down 23.43% YoY) and the FY2025 annual result came in at $14.9 million, down 20.89% from the prior year.
• Goodwill & Intangibles fell to $13.7 million in Q1 2026 per CPIX's latest filing, from $14.9 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $36.4 million in Q1 2022 and troughed at $13.7 million in Q1 2026.
• A 5-year average of $24.0 million and a median of $22.4 million in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles surged 30.48% in 2022, then decreased 27.49% in 2024.
• Over 5 years, Goodwill & Intangibles stood at $31.5 million in 2022, then slipped by 25.34% to $23.5 million in 2023, then retreated by 19.7% to $18.9 million in 2024, then decreased by 20.89% to $14.9 million in 2025, then fell by 8.26% to $13.7 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $13.7 million, $14.9 million, and $15.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.